We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. EuroPCR 2014 featured a wide variety of important ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- Repeat revascularizations almost derailed a ...
Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- Technical success of transcatheter mitral valve ...
SAN DIEGO, CHRON Volcano Corporation today announced its participation in the Paris course for Revascularization (EuroPCR) from May 17 — 20. Volcano's focus will be on highlighting the strength of its ...
1. The "Radial Paradox": Higher Femoral Access Site Complications Offsets Radial Benefits Growing acceptance of radial access during cardiac catheterisation to reduce access site complications may ...
Please provide your email address to receive an email when new articles are posted on . This year’s EuroPCR meeting, held in the Palais des Congrès in Paris, featured an all-time high turnout of more ...
Paris, France: Ongoing development of bioresorbable stent (BRS) technologies that are bioresorbed after achieving vessel expansion in percutaneous coronary intervention procedures is an important ...
On Thursday during a Hotline / Late-Breaking Trials session, Dr. Toru Tanigaki of Gifu Heart Center in Gifu, Japan, will present the one-year results of the PROVISION1 Study, the first-ever Japanese ...
NEW YORK, NY – The Cardiovascular Research Foundation (CRF) will hold a special session providing updates on several key cardiovascular trials on Tuesday, May 20 at this year’s EuroPCR meeting. The ...
PARIS, FRANCE – No one could accuse EuroPCR 2014 of giving up on renal denervation following the negative results of the only large, randomized, sham-controlled trial of this cutting-edge technology.
VANCOUVER and MINNEAPOLIS, May 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire-- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that it will sponsor a symposium presenting ...
Paris, France and Munich, Germany, 22 May, 2025 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, is presenting data in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results